Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Retatrutide achieved its outcome 2024 weeks faster than either comparator's trial endpoint
Most adverse events were self-limited and gastrointestinal in nature [113]
Reconstituting and self-administering peptides carries inherent risks including infection, contamination, and dosing errors
The Lancet, 392(10151), 21882199
STEP #2 Provider review A licensed medical provider reviews your information to determine if treatment is appropriate for you
US$ 25.48
US$ 29.29
US$ 29.87
US$ 26.26
US$ 23.25
US$ 26.10
US$ 22.09
US$ 28.44
US$ 26.71
US$ 28.40
US$ 29.54
US$ 21.86
